Data / Drug companies / Phendimetrazine tartrate
Phendimetrazine tartrate: 13 companies and 20 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Phendimetrazine tartrate is listed in the FDA National Drug Code Directory by 13 companies, with 20 products in commercial distribution. 19 of the products (95.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release, and the newest product started marketing on November 1, 2022.
The request: Get every company that lists phendimetrazine tartrate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 20
- Generic (ANDA) products
- 19 (95.0%)
- Application numbers
- 4
- Controlled substance schedule
- Schedule III
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list phendimetrazine tartrate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 3 | tablet | Generic drugs (ANDA) | September 15, 2010 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | July 1, 2018 |
| KVK-Tech, Inc. | 3 | tablet | Generic drugs (ANDA) | September 15, 2010 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet | Generic drugs (ANDA) | November 20, 2012 |
| Acertis Pharmaceuticals, LLC | 1 | capsule, extended release | New drug applications (NDA) | November 1, 2022 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | November 20, 2012 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | July 1, 2018 |
| Calvin Scott & Co., Inc. | 1 | tablet | Generic drugs (ANDA) | January 1, 1978 |
| Elite Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | November 20, 2012 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 15, 2010 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 15, 2010 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | August 13, 2018 |
| Virtus Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | July 1, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 19 | 95% |
| Capsule, extended release | 1 | 5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 19 | 95% |
| New drug applications (NDA) | 1 | 5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sympathomimetic Amine Anorectic | 20 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.